Discover

QTTB
Q32 Bio Inc.
15.27
2 x 15.11
10 x 15.69
bid
ask
-
0.14
0.91%
09:31 AM
timesize
Ytd359.94%
1y581.70%
15.06
day range
15.51
1.57
52 week range
23.57
Open15.18Prev Close15.41Low15.06High15.51Mkt Cap196.88M
Vol10.77KAvg Vol1.47MEPS1.73P/E8.91Forward P/E-0.60
Beta0.24Short Ratio6.74Inst. Own86.21%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0650-d Avg11.50200-d Avg5.961yr Est17.40
Income Statement
Operating Expenses7.72M
Research and Development Expense3.22M
Selling, General and Administrative Expense4.50M
Operating Income-7.72M
Net Income-7.61M
Net Income Common Stock-7.61M
Net Income Common Stock (USD)-7.61M
Consolidated Income-7.61M
Earnings per Basic Share-0.54
Earnings per Basic Share (USD)-0.54
Earnings per Diluted Share-0.54
Earning Before Interest & Taxes (EBIT)-7.61M
Earning Before Interest & Taxes (USD)-7.61M
Weighted Average Shares14.10M
Weighted Average Shares Diluted14.10M
Balance Sheet
Cash and Equivalents51.40M
Cash and Equivalents (USD)51.40M
Current Assets57.20M
Property, Plant & Equipment Net5.83M
Total Assets63.68M
Debt Current6.24M
Total Debt12.93M
Current Liabilities10.67M
Debt Non-Current6.69M
Total Liabilities17.36M
Accumulated Retained Earnings (Deficit)-212.60M
Shareholders Equity46.31M
Shareholders Equity (USD)46.31M
Assets Non-Current6.47M
Total Debt (USD)12.93M
Liabilities Non-Current6.69M
Trade and Non-Trade Payables653.00K
Cash Flow
Depreciation, Amortization & Accretion253.00K
Net Cash Flow from Financing8.80M
Net Cash Flow / Change in Cash & Cash Equivalents2.45M
Issuance (Purchase) of Equity Shares10.36M
Issuance (Repayment) of Debt Securities -1.56M
Net Cash Flow from Operations-6.34M
Share Based Compensation1.55M